EasyDNNNewsCalendar

Archive

EasyDNNNews

Tuesday, August 7, 2018

PET Tracer Identifies Estrogen Receptor Variation In Breast Cancer Patients, Study Indicates.

HealthImaging (8/7, O'Connor) reports Dutch researchers “utilized a PET tracer to distinguish differences in estrogen receptor (ER) expression in metastatic breast cancer patients” and their findings “may enhance treatment for these patients.” Geke A.P. Hospers, MD, PhD, and colleagues from the University of Groningen, said, “The results showed that approximately 50 percent of the patients had one or more estrogen-receptor negative lesions, while the primary tumor was estrogen-receptor positive.” The study was published in the Journal of Nuclear Medicine.

Print
Author: Nicole Hardy
0 Comments

Categories: 2018, August, News, Screening and MammographyNumber of views: 2581

Tags: